Comparison of two free light chain assays: performance of the free light chain ratio as risk factor for MGUS progression

被引：0
|
作者：
Wang, Qian [1 ]
Andress, Benjamin D. [1 ]
Pazdernik, Vanessa [1 ]
Larson, Dirk R. [1 ]
Coker, Jonathan D. [1 ]
Dasari, Surendra [1 ]
Rajkumar, Vincent [1 ]
Dispenzieri, Angela [1 ]
Murray, David [1 ]
Willrich, Maria Alice V. [1 ]
机构：
[1] Mayo Fdn Med Educ & Res, Rochester, MN USA
来源：
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2024年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
479
引用
收藏
页码：S199 / S199
页数：1
相关论文
共 50 条
  • [41] COMPARISON OF FREELITE AND N LATEX SERUM FREE LIGHT CHAIN ASSAYS AND PREDICTING SURVIVAL
    Mahmood, S.
    Wassef, N.
    Sachchithanantham, S.
    Rannigan, L.
    Taylor, W.
    Lane, T.
    Foard, D.
    Tekle, A.
    Patel, K.
    Pinney, J.
    Whelan, C.
    Lachmann, H.
    Gillmore, J.
    Hawkins, P.
    Wechalekar, A.
    HAEMATOLOGICA, 2013, 98 : 329 - 329
  • [42] Hook effect with lambda free light chain in serum free light chain assay
    Levinson, Stanley S.
    CLINICA CHIMICA ACTA, 2010, 411 (21-22) : 1834 - 1836
  • [43] Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio ≥100
    Alissa Visram
    S. Vincent Rajkumar
    Prashant Kapoor
    Angela Dispenzieri
    Martha Q. Lacy
    Morie A. Gertz
    Francis K. Buadi
    Suzanne R. Hayman
    David Dingli
    Taxiarchis Kourelis
    Wilson Gonsalves
    Rahma Warsame
    Eli Muchtar
    Nelson Leung
    Robert A. Kyle
    Shaji K. Kumar
    Leukemia, 2022, 36 : 1699 - 1699
  • [44] Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio
    Zach, David
    Ablasser, Klemens
    Kolesnik, Ewald
    Hoeller, Viktoria
    Fruhwald, Friedrich
    Prueller, Florian
    Reiter, Clemens
    Beham-Schmid, Christine
    Lipp, Rainer
    Rainer, Peter P.
    Zirlik, Andreas
    Woelfler, Albert
    Verheyen, Nicolas
    ESC HEART FAILURE, 2021, 8 (04): : 3397 - 3402
  • [45] ACCURACY OF THE SERUM TOTAL LIGHT CHAIN RATIO AS A PREDICTOR OF ABNORMAL SERUM FREE LIGHT CHAIN RATIOS
    Pereira, M.
    Costa e Silva, N.
    Geraldes, C.
    Ribeiro, L.
    Rodrigue, F.
    HAEMATOLOGICA, 2015, 100 : 520 - 520
  • [46] Serum Free Light Chain Assays Are More Sensitive Than Urinary Tests for Light Chain Monoclonal Proteins
    van Hoeven, K. H.
    Bilotti, E.
    McBride, L.
    Berges, T.
    McNeill, A.
    Schillen, D.
    Siegel, D.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A113 - A113
  • [47] Comparison of two serum free light chain assays for the diagnosis of primary plasma cell malignant proliferative disease
    Yang, Yang
    Han, Xiaoyan
    Zheng, Gaofeng
    Cai, Zhen
    HEALTH SCIENCE REPORTS, 2019, 2 (04)
  • [48] COMPARISON OF THE N-LATEX AND FREELITE ASSAYS FOR SERUM FREE LIGHT CHAIN: CLINICAL PERFORMANCE IN AL AMYLOIDOSIS
    Palladini, G.
    Jaccard, A.
    Milani, P.
    Lavergne, D.
    Foli, A.
    Bender, S.
    Lavatelli, F.
    Bosoni, T.
    Valentini, V.
    Pirolini, L.
    Albertini, R.
    Moratti, R.
    Cogne, M.
    Merlini, G.
    HAEMATOLOGICA, 2014, 99 : 359 - 359
  • [49] COMPARISON OF EFFICACY OF IMMUNOGLOBULIN FREE LIGHT CHAIN (FLC), HEAVY CHAIN/LIGHT CHAIN (HLC) ASSAYS AND IMMUNOFIXATION (IFE) IN ASSESSMENT OF REMISSION IN MULTIPLE MYELOMA (MM)
    Kraj, M.
    Kruk, B.
    Szczepinski, A.
    Warzocha, K.
    HAEMATOLOGICA, 2012, 97 : 605 - 605
  • [50] ABNORMAL SERUM FREE LIGHT CHAIN RATIO IS AN INDEPENDENT RISK FACTOR FOR RENAL IMPAIRMENT IN PATIENTS WITH MULTIPLE MYELOMA
    Hara, Masaki
    Tokoroyama, Takeshi
    Kawazoe, Kentarou
    Fujii, Teruhiro
    Nitta, Kosaku
    Ohta, Akihito
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 98 - 98
12345